Lv32
208 积分 2022-08-23 加入
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
7天前
已完结
Herb-drug interaction potential of Astragali Radix : a metabolic perspective
8天前
已完结
796P A phase II trial to evaluate the safety and efficacy of SSGJ-707: A bispecific antibody targeting PD-1 and VEGF, in combination with chemotherapy in patients with metastatic CRC
9天前
已关闭
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ study
15天前
已完结
Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody–drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study
15天前
已完结
β-Galactosidase-activated theranostic for hepatic carcinoma therapy and imaging
21天前
已完结
Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study
1个月前
已关闭
FOLFOXIRI plus bevacizumab as standard of care for first-line treatment in patients with advanced colon cancer
1个月前
已完结
Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4/IKK2/SNARE-Dependent Exocytosis
1个月前
已完结
Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4/IKK2/SNARE-Dependent Exocytosis
1个月前
已完结
皖公网安备34019202002308
